Based out of Dana-Farber Cancer Institute, the Promise Study is an initiative launched by the Stand Up to Cancer (SU2C) Multiple Myeloma “Dream Team” — a multidisciplinary, inter-institutional group focused on addressing critical problems in multiple myeloma prevention, diagnosis, and treatment. The Promise Study aims to identify people with conditions that are precursors of multiple myeloma and track their health over time.